Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer

OBJECTIVE: To assess the cost-effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer. METHODS: An analytical decision model was developed to determine the cost-effectiveness of chemohormonal therapy versus androgen deprivatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Einstein (Sao Paulo)
Autors principals: Aguiar, Pedro Nazareth, Barreto, Carmélia Maria Noia, Gutierres, Bárbara de Souza, Tadokoro, Hakaru, Lopes, Gilberto de Lima
Format: Artigo
Idioma:Inglês
Publicat: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2017
Matèries:
Health Economics and Management
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5823051/
https://ncbi.nlm.nih.gov/pubmed/29091159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1679-45082017GS4017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars